快速发展的HCC景观:选择最佳的全身疗法
Valentina Zanuso1,2, Lorenza Rimassa2,3, Chiara Braconi1,4
1School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Hepatology (Baltimore, Md.)
|September 11, 2023
概括
针对晚期肝细胞癌 (HCC) 的全身治疗改善了生存率. 像阿特佐利祖马布加贝瓦西祖马布这样的新疗法提供了更好的选择,但治疗选择取决于个体患者的因素.
科学领域:
- 肝细胞癌研究 肝细胞癌研究
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 晚期肝细胞癌 (HCC) 治疗已取得显著进展.
- 总体生存率有所改善,特别是在敏感瘤和良好的肝功能患者中.
- 治疗场景正在不断发展,新的一线药物和基于免疫检查点抑制剂的疗法.
研究的目的:
- 审查高级HCC的全身治疗选择中的进展.
- 讨论当前的护理标准和新兴疗法.
- 突出选择最佳治疗策略的复杂性.
主要方法:
- 审查最近的临床实践指南和先进的HCC的里程碑式试验.
- 对当前一线治疗方法的疗效和安全数据的分析.
- 讨论影响治疗选择的患者特定因素.
主要成果:
- 阿特佐利祖马布加贝瓦西祖马布和杜尔瓦卢马布加特梅利卢马布现在是治疗的标准,超过了像索拉费尼布和伦瓦提尼布这样的老药物.
- 治疗决策是患者驱动的,整合了疗效,并发症,肝功能和安全性.
- 用于患者分层的预测生物标志物仍在开发中.
结论:
- 晚期HCC的全身治疗已经显著扩大,提供了更好的结果.
- 个性化治疗选择至关重要,因为没有对所有选择进行对比.
- 随着治疗转移到早期疾病阶段,治疗算法的复杂性正在增加.
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21Hepatic Portal System
1.5K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.5K
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K